Simonetta Falzoni, Anna Lisa Giuliani, Elena Adinolfi, Robson Coutinho-Silva, Peter Illes, Simon C Robson, Yong Tang, Henning Ulrich, Charles Kennedy
{"title":"In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend.","authors":"Simonetta Falzoni, Anna Lisa Giuliani, Elena Adinolfi, Robson Coutinho-Silva, Peter Illes, Simon C Robson, Yong Tang, Henning Ulrich, Charles Kennedy","doi":"10.1007/s11302-026-10135-9","DOIUrl":null,"url":null,"abstract":"<p><p>Francesco Di Virgilio, one of the giants of purinergic signalling, died suddenly on September 22, 2024, which is an immense loss to so many friends and colleagues and especially to his beloved wife, Dorianna. Here, 1 year on, we pay tribute to him and his immense contribution to our field. Francesco graduated in medicine from the University of Padova, Italy, in 1979, with what became a lifelong interest in inflammation. He then held post-doctoral positions at University College London, Padova University, and Columbia University, New York, where he became acquainted with P2X7 receptors. He then returned to Padova as an Associate Professor of Molecular Pathology before moving to the University of Ferrara in 1992, where he set up a world-leading lab that studied the roles and underlying cellular mechanisms of the action of P2X7 receptors in inflammatory pathologies. Francesco published over 370 peer-reviewed articles, which have been cited > 35,000 times, giving him an H-index > 100. In addition, he filed several patents related to purinergic signalling. He also collaborated extensively, both within the University of Ferrara and worldwide, including in universities in the UK, Spain, Germany, the USA, and Brazil. Francesco was a man of great passion and intellect, who possessed scientific vision, intuition, and integrity, and he became the go-to world expert on P2X7 receptors and inflammation. We have lost a giant in the field and a dear friend, but he leaves behind an exceptional body of work, an outstanding legacy, and many friends who will miss him.</p>","PeriodicalId":20952,"journal":{"name":"Purinergic Signalling","volume":"22 1","pages":"20"},"PeriodicalIF":2.5000,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12900987/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Purinergic Signalling","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11302-026-10135-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Francesco Di Virgilio, one of the giants of purinergic signalling, died suddenly on September 22, 2024, which is an immense loss to so many friends and colleagues and especially to his beloved wife, Dorianna. Here, 1 year on, we pay tribute to him and his immense contribution to our field. Francesco graduated in medicine from the University of Padova, Italy, in 1979, with what became a lifelong interest in inflammation. He then held post-doctoral positions at University College London, Padova University, and Columbia University, New York, where he became acquainted with P2X7 receptors. He then returned to Padova as an Associate Professor of Molecular Pathology before moving to the University of Ferrara in 1992, where he set up a world-leading lab that studied the roles and underlying cellular mechanisms of the action of P2X7 receptors in inflammatory pathologies. Francesco published over 370 peer-reviewed articles, which have been cited > 35,000 times, giving him an H-index > 100. In addition, he filed several patents related to purinergic signalling. He also collaborated extensively, both within the University of Ferrara and worldwide, including in universities in the UK, Spain, Germany, the USA, and Brazil. Francesco was a man of great passion and intellect, who possessed scientific vision, intuition, and integrity, and he became the go-to world expert on P2X7 receptors and inflammation. We have lost a giant in the field and a dear friend, but he leaves behind an exceptional body of work, an outstanding legacy, and many friends who will miss him.
弗朗切斯科·迪·维吉利奥,嘌呤能信号的巨人之一,于2024年9月22日突然去世,这对许多朋友和同事来说是一个巨大的损失,尤其是对他深爱的妻子多里安娜。在这里,一年过去了,我们向他和他对我们这个领域的巨大贡献致敬。1979年,弗朗西斯科从意大利帕多瓦大学(University of Padova)医学专业毕业,并对炎症产生了毕生的兴趣。随后,他在伦敦大学学院、帕多瓦大学和纽约哥伦比亚大学担任博士后,在那里他熟悉了P2X7受体。1992年,他来到费拉拉大学,在那里他建立了一个世界领先的实验室,研究P2X7受体在炎症病理中的作用和潜在的细胞机制。弗朗西斯科发表了370多篇同行评议的文章,被引用35000次,h指数100。此外,他还申请了几项与嘌呤能信号相关的专利。他还与费拉拉大学和世界各地的大学进行了广泛的合作,包括英国、西班牙、德国、美国和巴西的大学。弗朗西斯科是一个充满激情和智慧的人,他拥有科学的眼光、直觉和正直,他成为了P2X7受体和炎症的世界专家。我们失去了这个领域的一位巨人和一位亲爱的朋友,但他留下了一份非凡的工作,一份杰出的遗产,以及许多会想念他的朋友。
期刊介绍:
Nucleotides and nucleosides are primitive biological molecules that were utilized early in evolution both as intracellular energy sources and as extracellular signalling molecules. ATP was first identified as a neurotransmitter and later as a co-transmitter with all the established neurotransmitters in both peripheral and central nervous systems. Four subtypes of P1 (adenosine) receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of P2Y G protein-coupled receptors have currently been identified. Since P2 receptors were first cloned in the early 1990’s, there is clear evidence for the widespread distribution of both P1 and P2 receptor subtypes in neuronal and non-neuronal cells, including glial, immune, bone, muscle, endothelial, epithelial and endocrine cells.